Binge eating disorder: An emerging entity that responds to pharmacotherapy;Transtorno da compulsão alimentar periódica: Uma entidade clínica emergente que responde ao tratamento farmacológico

Revista Brasileira de Psiquiatria

Volumn 26, Issue 2, 2004, Pages 75-76

  Appolinario, José Carlos ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIOBESITY AGENT; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SIBUTRAMINE; TOPIRAMATE;

ANXIETY; BINGE EATING DISORDER; CLINICAL FEATURE; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIET THERAPY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG RESPONSE; EDITORIAL; HUMAN; IMPULSIVENESS; OBESITY; PSYCHOTHERAPY; SYMPTOM;

EID: 3142707909     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-44462004000200002     Document Type: Editorial

References (6)

1. Stunkard AJ. Eating patterns and obesity. Psychiatr Q. 1959;33:284-95.
2. Devlin MJ, Goldfein JA, Dobrow I. What is this thing called BED? Current status of binge eating disorder nosology. Int J Eat Disord. 2003;34[suppl.]:S2- S18.
3. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 2003;160:4-12.
4. Appolinario JC, Bacaltchuck J, Sichieri R, Claudino AM, Godoy-Mattos, Morgan C, Zanella MT, Coutinho W. A randomized, double-blind placebo controlled study of sibutramine in the treatment of binge-eating disorder. Arch Gen Psychiatry. 2003;60:1109-16.
5. Appolinario JC, Mc Elroy SL. Pharmacological approaches for the treatment of binge-eating disorder. Curr Drug Targets 2004;5(3):301-7.
6. Versiani M. A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia). World J Biol Psychiatry 2000;1(1):27-33.